Medication-Related Osteonecrosis of the Jaw in a Patient With Prostate Cancer: A Case Presentation With a One-Month Follow-Up

Read full text
Authors: Charbel F Kachouh, Adam M Aboukhalil, Rosine H Hajj Chehadeh, Robert S Daccache, Hiam Y Wehbe, Samar A Bou Jaoude
Cited by: 1
References: 19

Abstract

Medication-related osteonecrosis of the jaw (MRONJ) is an adverse event that most commonly occurs in patients undergoing bisphosphonate therapy and remains a significant challenge for dentists. Its clinical presentation varies according to the stages of the disease, depending on clinical and radiological findings. We report the case of an 81-year-old man presenting with a cutaneous fistula and purulent drainage from the lower right side of the mandible. The patient was under chemotherapy and receiving zoledronic acid treatment, administered as an intravenous injection every six months for 10 years. Oral manifestations of MRONJ can present with diverse lesions requiring careful clinical evaluation, accurate diagnosis, and appropriate management.

Fields of Study & Subjects

Bone health and treatments Oral health in cancer treatment Parathyroid Disorders and Treatments

Publication details

Journal / source
Cureus
Publisher
Springer Science and Business Media LLC
Volume
18
Issue
6
Pages
e110302–e110302
Publication date
5 June 2026
Language
EN